FIELD: medicine, biotechnology, immunology. SUBSTANCE: the present innovation deals with preparations stimulating antibody-forming and could be applied in the field of medicine and veterinary science to constructing and manufacturing highly efficient vaccines. Adjuvant for biopreparations contains distilled water, conservant and nonionogenic SAS as foundation. Additionally, adjuvant contains immunomodulator as fat- and/or water-soluble vitamins, and cosolvent, as well. The adjuvant elaborated enables to create vaccines of low toxicity, increased immunogenic activity, stability of immunogenic properties at storage and low cost price of production. EFFECT: higher efficiency. 3 cl, 9 ex, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
ADJUVANT | 2001 |
|
RU2218937C2 |
IMMUNOGENIC COMPOSITION | 2005 |
|
RU2308289C2 |
AQUEOUS-DISPERSED MEDICINAL FORM OF IVERMECTIN FOR TREATMENT OF ECTO- AND ENDOPARASITOSIS | 2000 |
|
RU2162699C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DISEASES OF BACTERIAL AND PARASITIC ETIOLOGY | 2003 |
|
RU2273480C2 |
INJECTION MEDICINAL FORM OF METRONIDAZOLE | 2000 |
|
RU2173993C1 |
RECOMBINANT VACCINE FOR PREVENTING VIRAL HEPATITIS B (VARIANTS) | 2003 |
|
RU2238105C1 |
METHOD FOR PREPARING HEPATITIS B VIRUS SURFACE ANTIGEN FROM RECOMBINANT YEAST CELLS HANSENULA POLYMORPHA AND VACCINE FOR IMMUNIZATION AGAINST HEPATITIS B | 2002 |
|
RU2205023C1 |
VACCINE OVAC FOR CONTROL OVER SYNDROME OF EGG YIELD DECREASE - 76 POULTRY | 1995 |
|
RU2097066C1 |
METHOD OF PRODUCING TETRAVALENT SUBUNIT INFLUENZA VACCINE | 2019 |
|
RU2740751C1 |
PHARMACEUTICAL COMPOSITION FOR VIRAL HEPATITIS B PROPHYLAXIS | 1998 |
|
RU2135209C1 |
Authors
Dates
2003-10-20—Published
2002-05-27—Filed